MeHow Innovative Future Growth
Future criteria checks 5/6
MeHow Innovative is forecast to grow earnings and revenue by 32.3% and 26.6% per annum respectively. EPS is expected to grow by 32.2% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
32.3%
Earnings growth rate
32.2%
EPS growth rate
| Medical Equipment earnings growth | 23.4% |
| Revenue growth rate | 26.6% |
| Future return on equity | 13.3% |
| Analyst coverage | Low |
| Last updated | 22 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,606 | 620 | 224 | 525 | 5 |
| 12/31/2025 | 2,083 | 493 | 137 | 426 | 5 |
| 12/31/2024 | 1,660 | 393 | 93 | 347 | 5 |
| 6/30/2024 | 1,290 | 242 | 96 | 356 | N/A |
| 3/31/2024 | 1,252 | 263 | 109 | 363 | N/A |
| 12/31/2023 | 1,338 | 313 | 92 | 351 | N/A |
| 9/30/2023 | 1,391 | 375 | 208 | 450 | N/A |
| 6/30/2023 | 1,495 | 457 | 134 | 352 | N/A |
| 3/31/2023 | 1,498 | 443 | 198 | 414 | N/A |
| 1/1/2023 | 1,415 | 402 | 180 | 381 | N/A |
| 9/30/2022 | 1,381 | 401 | 38 | 235 | N/A |
| 6/30/2022 | 1,303 | 363 | -107 | 306 | N/A |
| 3/31/2022 | 1,168 | 311 | -175 | 182 | N/A |
| 1/1/2022 | 1,137 | 310 | -120 | 196 | N/A |
| 12/31/2020 | 888 | 258 | 63 | 303 | N/A |
| 12/31/2019 | 742 | 232 | 105 | 223 | N/A |
| 12/31/2018 | 582 | 131 | 105 | 168 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301363's forecast earnings growth (32.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 301363's earnings (32.3% per year) are forecast to grow faster than the CN market (22.9% per year).
High Growth Earnings: 301363's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301363's revenue (26.6% per year) is forecast to grow faster than the CN market (13% per year).
High Growth Revenue: 301363's revenue (26.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 301363's Return on Equity is forecast to be low in 3 years time (13.3%).